Zelira Therapeutics: Launches Hope products in Australia

  • Zelira Therapeutics (ZLD) has launched its Hope products in Australia after receiving Therapeutic Goods Administration (TGA) approval
  • The two proprietary cannabinoid formulations, Hope 1 and Hope 2, were developed to support the needs of patients with Autism Spectrum Disorder
  • The Hope products were launched in the U.S. state of Pennsylvania last year and Louisiana in August this year
  • In August this year, the products were also launched in Louisiana, in partnership with Advanced Biomedics
  • The company has now launched five products in 2020
  • Following today’s announcement, Zelia shares are up 8.86 percent, priced at 8.6 cents at 10:48 am AEDT
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

ECB Strengthens Framework Ahead of Planned Digital Euro Pilots

European Central Bank prepares for digital euro testing phase.Highlights: ECB announces enhancements to its regulatory framework.Planned pilots for...

Mastercard and Visa Strengthen Agentic Payment Pilots with Bank Collaborations

Financial giants team up with banks to enhance payment systems.Highlights: Mastercard and Visa partner with banks for innovative...

Mastercard Strengthens Cyber Defense with Cloudflare Partnership

New alliance enhances transaction security amidst rising cyber threats.Highlights: Mastercard partners with Cloudflare for enhanced cyber security.Collaboration aims...

Gemini Stock Plummets as Three Top Executives Depart

Key leadership changes raise concerns over Gemini's future stability.Highlights: Gemini stock drops significantly after three executives resign.Executive departures...